Broad Institute, Inc. is > 10% Shareholder of Verve Therapeutics, Inc.. Currently has a direct ownership of 809,784 shares of VERV, which is worth approximately $3.92 Million. The most recent transaction as insider was on Jun 21, 2021, when has been sold 387,830 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 810K
0% 3M change
0% 12M change
Total Value Held $3.92 Million

Broad Institute, Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2021
BUY
Other acquisition or disposition
-
387,830 Added 32.38%
809,784 Common Stock
BII

Broad Institute, Inc.

> 10% Shareholder
Cambridge, MA

Track Institutional and Insider Activities on VERV

Follow Verve Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERV shares.

Notify only if

Insider Trading

Get notified when an Verve Therapeutics, Inc. insider buys or sells VERV shares.

Notify only if

News

Receive news related to Verve Therapeutics, Inc.

Track Activities on VERV